User profiles for Therese A. Stukel
Therese A StukelInstitute for Clinical Evaluative Sciences; University of Toronto Verified email at ices.on.ca Cited by 43895 |
Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and …
ContextComparisons of outcomes between patients treated and untreated in observational
studies may be biased due to differences in patient prognosis between groups, often …
studies may be biased due to differences in patient prognosis between groups, often …
[HTML][HTML] A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin
Background. Beta carotene has been associated with a decreased risk of human cancer in
many studies employing dietary questionnaires or blood measurements, and it has had …
many studies employing dietary questionnaires or blood measurements, and it has had …
Generalized logistic models
TA Stukel - Journal of the American Statistical Association, 1988 - Taylor & Francis
A class of models indexed by two shape parameters is introduced, both to extend the scope
of the standard logistic model to asymmetric probability curves and improve the fit in the …
of the standard logistic model to asymmetric probability curves and improve the fit in the …
Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer
Objective. —The primary aims of this study were to assess risk of subsequent basal and
squamous cell skin cancer among patients with a prior history of these tumors and to examine …
squamous cell skin cancer among patients with a prior history of these tumors and to examine …
Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA
…, ER Greenberg, SK Spencer, TA Stukel… - … journal of cancer, 1999 - Wiley Online Library
We conducted a study to estimate the current incidence rates of basal‐cell carcinoma (BCC)
and squamous‐cell carcinoma (SCC) of the skin in the population of New Hampshire (NH), …
and squamous‐cell carcinoma (SCC) of the skin in the population of New Hampshire (NH), …
Immunohistochemical Staining for Transforming Growth Factor β1 Associates with Disease Progression in Human Breast Cancer
SM Gorsch, VA Memoli, TA Stukel, LI Gold, BA Arrick - Cancer research, 1992 - AACR
The transforming growth factor βs (TGF-β) comprise a family of M r 25,000 pluripotent growth
factors which have been implicated in the development and progression of human breast …
factors which have been implicated in the development and progression of human breast …
Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy
…, ER Greendberg, TA Stukel… - JNCI: Journal of the …, 1996 - academic.oup.com
Background Human evidence that ionizing radiation is carcinogenic first came from reports
of nonmelanoma skin cancers (NMSCs) on the hands of workers using early radiation …
of nonmelanoma skin cancers (NMSCs) on the hands of workers using early radiation …
Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States
Objective To evaluate the use of healthcare resources during the last six months of life among
patients of US hospitals with strong reputations for high quality care in managing chronic …
patients of US hospitals with strong reputations for high quality care in managing chronic …
[HTML][HTML] The relation between the availability of neonatal intensive care and neonatal mortality
Background There is marked regional variation in the availability of neonatal intensive care
in the United States. We conducted a study to determine whether a greater supply of …
in the United States. We conducted a study to determine whether a greater supply of …
Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease
Importance Chronic obstructive pulmonary disease (COPD) is a common and deadly disease.
Long-acting inhaled β-agonists and anticholinergics, first-line medications for COPD, …
Long-acting inhaled β-agonists and anticholinergics, first-line medications for COPD, …